𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of Noben (idebenone) in the Treatment of Dementia and Memory Impairments without Dementia

✍ Scribed by K. V. Voronkova; M. N. Meleshkov

Book ID
106479012
Publisher
Springer US
Year
2009
Tongue
English
Weight
617 KB
Volume
39
Category
Article
ISSN
0097-0549

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Incidence of dementia and cognitive impa
Incidence of dementia and cognitive impairment, not dementia in the united states
✍ Brenda L. Plassman; Kenneth M. Langa; Ryan J. McCammon; Gwenith G. Fisher; Guy G πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 2 views

## Abstract ## Objective: Estimates of incident dementia, and cognitive impairment, not dementia (CIND) (or the related mild cognitive impairment) are important for public health and clinical care policy. In this paper, we report US national incidence rates for dementia and CIND. ## Methods: Par

Neuroleptics in the treatment of dementi
Neuroleptics in the treatment of dementia
✍ Dr. Trey Sunderland; Michael A. Silver πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 659 KB

The authors review the history of neuroleptic treatment in dementia. The initial review of 34 studies published since 1954 was limited to the 20 double-blind and/or placebo-controlled studies. Sixty per cent of the studies revealed generally positive clinical results in demented patients following n

Concepts of mild memory impairment in th
Concepts of mild memory impairment in the elderly and their relationship to dementiaβ€”a review
✍ Bridget Dawe; Andrew Procter; Michael Philpot πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 684 KB

## Abstract The concept enshrined by Kral (1962) in the term β€˜benign senescent forgetfulness’ is reviewed together with a number of other diagnostic terms synonymous with mild memory impairment. Data from epidemiological studies which employ them are presented and the relationship between β€˜normal’

The progression of cognitive impairment
The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease
✍ C. Ballard; J. O'Brien; C. M. Morris; R. Barber; A. Swann; D. Neill; I. McKeith πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

## Abstract ## Background Little is known about the rate of progression or associations of cognitive impairment in dementia with Lewy bodies (DLB), or the associations of accelerated decline. ## Method Dementia patients from a case register were evaluated at baseline and 1 year follow‐up using t

Cholinesterase inhibitors in the treatme
Cholinesterase inhibitors in the treatment of dementia
✍ Maria Luisa Margallo-Lana; Clive Ballard; Chris Morris; David Kay; Stephen Tyrer πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 36 KB

fact may be ascribed to a primarily biological origin of the disease, not correlated with other possible causative events (e.g. chronic somatic diseases). On the other hand, in patients with reactive depressive symptoms a higher prevalence of somatic dysfunction (e.g. number of diseases, Charlson In